Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival (Annals of Hematology, (2018), 97, 9, (1671-1682), 10.1007/s00277-018-3361-2)

Autor: Katodritou, E. Kyrtsonis, M.-C. Delimpasi, S. Kyriakou, D. Symeonidis, A. Spanoudakis, E. Vasilopoulos, G. Anagnostopoulos, A. Kioumi, A. Zikos, P. Aktypi, A. Briasoulis, E. Megalakaki, A. Repousis, P. Adamopoulos, I. Gogos, D. Kotsopoulou, M. Pappa, V. Papadaki, E. Fotiou, D. Nikolaou, E. Giannopoulou, E. Hatzimichael, E. Giannakoulas, N. Douka, V. Kokoviadou, K. Timotheatou, D. Terpos, E.

The original version of this article contained a mistake. The name of Eirini Katroditou should have been Eirini Katodritou. The original article has been corrected. © 2018, The Author(s).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::f33ef854dffeb283381ed05155066814
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107118

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study.

Autor: Kattamis A; First Department of Pediatrics Thalassemia Unit National and Kapodistrian University of Athens Athens Greece., Voskaridou E; Expertise Center in Rare Haematological Diseases-Haemoglobinopathies General Hospital of Athens 'Laikon' Athens Greece., Delicou S; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Hippocrateion' Athens Greece., Klironomos E; Thalassemia and Sickle Cell Unit General Hospital of Heraklion 'Venizelion' Heraklion Greece., Lafiatis I; Thalassemia and Sickle Cell Unit General Hospital of Mytilene 'Vostanio' Mytilene Greece., Petropoulou F; Thalassemia Unit General Hospital of Athens 'Georgios Gennimatas' Athens Greece., Diamantidis MD; Thalassemia and Sickle Cell Disease Unit General Hospital of Larissa 'Koutlimbaneio & Triantafylleio' Larissa Greece., Lafioniatis S; Thalassemia and Sickle Cell Unit General Hospital of Volos 'Achilopouleio,' Volos Greece., Evliati L; Thalassemia and Sickle Cell Unit General Hospital of Athens 'Evaggelismos' Athens Greece., Kapsali E; Department of Hematology University Hospital of Ioannina Ioannina Greece., Karvounis-Marolachakis K; Medical Department Genesis Pharma SA Athens Greece., Timotheatou D; Medical Department Genesis Pharma SA Athens Greece., Deligianni C; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Viktoratos P; Medical Department Bristol-Myers Squibb Company SA Athens Greece., Kourakli A; Department of Internal Medicine Hematology Division University General Hospital of Patras Patras Greece.

Publikováno v: EJHaem [EJHaem] 2023 May 23; Vol. 4 (3), pp. 569-581. Date of Electronic Publication: 2023 May 23 (Print Publication: 2023).